JP2006117573A5 - - Google Patents

Download PDF

Info

Publication number
JP2006117573A5
JP2006117573A5 JP2004306042A JP2004306042A JP2006117573A5 JP 2006117573 A5 JP2006117573 A5 JP 2006117573A5 JP 2004306042 A JP2004306042 A JP 2004306042A JP 2004306042 A JP2004306042 A JP 2004306042A JP 2006117573 A5 JP2006117573 A5 JP 2006117573A5
Authority
JP
Japan
Prior art keywords
erythritol
xylitol
liquid oral
composition
cationic fungicide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004306042A
Other languages
Japanese (ja)
Other versions
JP4681269B2 (en
JP2006117573A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2004306042A priority Critical patent/JP4681269B2/en
Priority claimed from JP2004306042A external-priority patent/JP4681269B2/en
Publication of JP2006117573A publication Critical patent/JP2006117573A/en
Publication of JP2006117573A5 publication Critical patent/JP2006117573A5/ja
Application granted granted Critical
Publication of JP4681269B2 publication Critical patent/JP4681269B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (3)

次の成分（Ａ）、（Ｂ）及び（Ｃ）：
（Ａ）エリスリトール、キシリトール及びパラチニットからなる群より選ばれる１種又は２種以上、
（Ｂ）カチオン性殺菌剤、
（Ｃ）マルチトール及び／又はラクチトール
を含有する液体口腔用組成物。 The following components (A), (B) and (C):
(A) one or more selected from the group consisting of erythritol, xylitol and paratinite,
(B) a cationic fungicide,
(C) A composition for liquid oral cavity containing maltitol and / or lactitol. さらにエタノールを含有する請求項１記載の液体口腔用組成物。   Furthermore, the liquid oral composition of Claim 1 containing ethanol. （Ａ）エリスリトール、キシリトール及び／又はパラチニット、並びに（Ｂ）カチオン性殺菌剤を有効成分とする歯表面のペリクル形成抑制剤。 A tooth surface pellicle formation inhibitor comprising (A) erythritol, xylitol and / or palatinit , and (B) a cationic fungicide as active ingredients.
JP2004306042A 2004-10-20 2004-10-20 Liquid oral composition Active JP4681269B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004306042A JP4681269B2 (en) 2004-10-20 2004-10-20 Liquid oral composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004306042A JP4681269B2 (en) 2004-10-20 2004-10-20 Liquid oral composition

Publications (3)

Publication Number Publication Date
JP2006117573A JP2006117573A (en) 2006-05-11
JP2006117573A5 true JP2006117573A5 (en) 2007-07-05
JP4681269B2 JP4681269B2 (en) 2011-05-11

Family

ID=36535807

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004306042A Active JP4681269B2 (en) 2004-10-20 2004-10-20 Liquid oral composition

Country Status (1)

Country Link
JP (1) JP4681269B2 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009325A1 (en) * 1978-09-01 1980-04-02 Pfizer Inc. Erythritol cointaining anti-caries compositions
JPH06336416A (en) * 1993-05-28 1994-12-06 Sunstar Inc Dentifrice composition
JP2000154127A (en) * 1998-11-18 2000-06-06 Lion Corp Composition for oral cavity
JP2000344641A (en) * 1999-06-02 2000-12-12 Lion Corp Composition for oral cavity
JP2001139442A (en) * 1999-08-27 2001-05-22 Lion Corp Liquid composition for oral cavity
JP3783762B2 (en) * 1999-12-24 2006-06-07 ライオン株式会社 Stain removal oral composition
JP4044748B2 (en) * 2001-10-17 2008-02-06 サンスター株式会社 Oral liquid composition
JP4440622B2 (en) * 2002-12-12 2010-03-24 花王株式会社 Bad breath component cleaning composition and oral composition containing the same, chewing gum and refreshing confectionery in mouth

Similar Documents

Publication Publication Date Title
EP1741712A3 (en) Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of Nebivolol
JP2004529078A5 (en)
JP2004523498A5 (en)
JP2003503454A5 (en)
ATE537828T1 (en) PSYCHOTROPIC AGENTS AND FOODS FOR PROMOTING HEALTH CONTAINING NEFERINE
JP2006515598A5 (en)
EA200702198A1 (en) PHARMACEUTICAL COMPOSITIONS
TR200001810A3 (en) Immediate Melting Oral Dosage Formulation.
NO20080827L (en) Solid dosage formulations of narcotic drugs that have improved buccal adsorption
NO20034612L (en) 3,4-di-substituted cyclobutene-1,2-dione, pharmaceutical compositions comprising the compounds, and use of the compounds for the manufacture of medicaments for the treatment of chemokine-mediated diseases
ZA200802454B (en) Use of thienopyridone derivatives as AMPK activators and pharmaceutical compositions containing them
HUP0401714A2 (en) Oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient
BR0306870A (en) Oral pharmaceutical composition and method for preparing the same
JP2006502187A5 (en)
JP2008515980A5 (en)
MY141243A (en) Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus
JP2005513006A5 (en)
WO2006053089A3 (en) Methods and formulations for making pharmaceutical compositions containing bupropion
JP2004532828A5 (en)
JP2003507380A5 (en)
EA201101119A1 (en) DOSABLE FORM CONTAINING PANTOPRAZOL AS AN ACTIVE INGREDIENT
JP2006516141A5 (en)
WO2005120518A3 (en) Use of atp analogues for treatment of cardiovascular diseases
WO2004098577A3 (en) Dosage form containing (s)-pantoprazole as active ingredient
JP2006117573A5 (en)